Rosuvastatin Calcium Tablet, Film Coated
Product Images NDC 68788-8368

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 68788-8368). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc.,, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rosuvastatin Tablets 5mg (E432e043 C019 4d58 94ca 7c1d85f5cd40 00)

Label for Rosuvastatin Tablets 5 mg film-coated tablets, a generic for Crestor, manufactured by Glenmark Pharmaceuticals Inc. The label includes storage instructions to keep at 20° to 25°C and protect from moisture. It also features dosing instructions sections in English and Spanish, a barcode, and fields for lot number, batch number, and expiration date.*

FDA Label Image

Figure1 (Figure1)

A box plot chart comparing the percent change from baseline in LDL-C for four statins: Rosuvastatin, Atorvastatin, Simvastatin, and Pravastatin at various doses. The horizontal axis lists the drugs and their doses in milligrams, while the vertical axis shows the percent change from baseline ranging from 0 to -75. Each box plot visualizes the distribution of LDL-C changes for each drug dose group.*

FDA Label Image

Figure2 (Figure2)

A cumulative incidence graph comparing Rosuvastatin calcium 5 mg oral tablets (Rosuva) versus placebo over 5 years. The Y-axis shows cumulative incidence percentage, and the X-axis shows time in years. The graph includes hazard ratio (HR 0.56), 95% confidence interval, and p-value indicating statistical significance. A table below displays the number of patients at risk over time for both groups.*

FDA Label Image

Figure3 (Figure3)

A data table comparing the number of events and hazard ratios for Rosuva 20 mg versus placebo 20 mg across multiple cardiovascular endpoints, including cardiovascular death, nonfatal stroke, nonfatal myocardial infarction, hospitalized unstable angina, and arterial revascularization. The table presents event counts, rates, hazard ratios with 95% confidence intervals, and p-values for each endpoint, illustrating statistical analysis of treatment effects.*

FDA Label Image

Logo (Logo)

FDA Label Image

Logo1 (Logo1)

FDA Label Image

Https://tse3.mm.bing.net/th?id=oip.qkzjzqqg2qzrc4hvs4ecawaaaa&pid=api&p=0 (Structure)

Chemical structure of rosuvastatin calcium displaying its molecular arrangement, including aromatic rings, hydroxyl groups, and calcium ion association.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.